These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11180025)

  • 1. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.
    Rosenzweig P; Thebault JJ; Caplain H; Dubruc C; Bianchetti G; Fuseau E; Morselli PL
    Ann Allergy; 1992 Aug; 69(2):135-9. PubMed ID: 1354949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine.
    Jauregizar N; de la Fuente L; Lucero ML; Sologuren A; Leal N; Rodríguez M
    Clin Pharmacokinet; 2009; 48(8):543-54. PubMed ID: 19705924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
    Wang RQ; Zhang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine.
    Urien S; Tillement JP; Ganem B; Kuch MD
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):499-502. PubMed ID: 10543317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine.
    Pinquier JL; Caplain H; Cabanis MJ; Dubruc C; Stalla-Bourdillon A; Rosenzweig P
    J Clin Pharmacol; 1996 Jan; 36(1):72-8. PubMed ID: 8932546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
    Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
    Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
    Leroy T; van Neste D
    Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
    Purohit A; Mélac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
    Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
    Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.
    Devalia JL; De Vos C; Hanotte F; Baltes E
    Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of subsensitivity to mizolastine over 8-week treatment.
    Bousquet J; Chanal I; Murrieta M; Stalla-Bourdillon A
    Allergy; 1996 Apr; 51(4):251-6. PubMed ID: 8792922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
    Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
    Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.